We believe this site might serve you best::

United States

United States

Choose language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Ribo m7G Cap Analog

Enhances Translation Efficiency in Reticulocyte-Based Reactions

  • Protects RNA from intracellular digestion
  • Can be used with Riboprobe® or RiboMAX™ RNA production systems

Size

Catalog number selected: P1711

$ 147.00 Your price: Log In

Add to Helix Add to Helix
Ribo m7G Cap Analog
10 A254 units
$ 147.00
Your price: Log In
Change Configuration

The Ribo m7G Cap Analog is a modified ribonucleotide with the structure (m7G(5´)ppp(5´)G). This methylated ribonucleotide can be incorporated onto the 5´-end of transcripts synthesized in vitro and simulates the 7-methyl guanosine 5´-cap structure found on most eukaryotic mRNA molecules.

Protocols

Specifications

You are viewing: 10 A254 units Change Configuration

What's in the box?

Item Part # SizeConcentration

Ribo m7G Cap Analog

P171A 1 x 10 A254 units40mM

SDS

Choose language:

Certificate of Analysis

Search for Specific Certificate:

View more results
No results
Loading…

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Storage Conditions

BB

Specifications

You are viewing: 25 A254 units Change Configuration

What's in the box?

Item Part # SizeConcentration

Ribo m7G Cap Analog

P171B 1 x 25 A254 units40mM

SDS

Choose language:

Certificate of Analysis

Search for Specific Certificate:

View more results
No results
Loading…

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Storage Conditions

BB

Resources

Choose your country

Americas

Brazil
Brazil
Canada
Canada
United States
United States

Pacific Asia

Australia
Australia
India
India
Japan
Japan
Korea, Republic of
Korea, Republic of
Singapore
Singapore

Europe

Austria
Austria
Belgium
Belgium
Denmark
Denmark
Estonia
Estonia
Finland
Finland
France
France
Germany
Germany
Iceland
Iceland
Italy
Italy
Luxembourg
Luxembourg
Netherlands
Netherlands
Norway
Norway
Poland
Poland
Spain
Spain
Sweden
Sweden
Switzerland
Switzerland
United Kingdom
United Kingdom